Pricing Log in Create free account
Saturday 17 October 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024. In the quarter to June 2026, revenue grew 13.8%, EPS grew 19.2%, free cash flow fell 20.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.

382.92 0.10 −0.03%
Market cap
$27.0B
P/E
48.7×
Fwd P/E
37.3×
Dividend yield
0.23%
F-score
8/9
Altman Z
13.89
Beneish M
−2.79
Dividend safety
100/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

West Pharmaceutical Services, Inc. (WST) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, West Pharmaceutical Services, Inc. (WST) trades at a EV/Sales of 8.1×. Over the past ten years it has ranged from 2.5× (February 2015) to 13.6× (September 2021); the current reading is higher than 71% of that period. That is above the Medical Instruments & Supplies industry median of 2.9× and above the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 6.3× (23.11%)
FY2024 8.2× (4.12%)
FY2023 8.5× 46.79%
FY2022 5.8× (52.15%)
FY2021 12.1× 26.55%
FY2020 9.6× 61.17%
FY2019 5.9× 43.77%
FY2018 4.1× (9.58%)
FY2017 4.6× 11.59%
FY2016 4.1× 33.74%

Quarterly newest first

Period EV/Sales Change
Jun 2026 7.6× 37.55%
Mar 2026 5.5× (12.36%)
Dec 2025 6.3× 2.36%
Sep 2025 6.1× 17.24%
42 more quarters

Against its own ten years

Low 2.5× High 13.6×
Ten-year median 6.0×
Current reading's percentile 68

EV/Sales against peers

Company EV/Sales
MDLN Medline Inc. compare 1.4×
BAX Baxter International Inc. compare 1.8×
SOLV Solventum Corporation compare 2.4×
BDX Becton, Dickinson and Company compare 2.9×
COO The Cooper Companies, Inc. compare 3.2×
ALC Alcon compare 3.3×
RMD ResMed Inc. compare 6.0×
WST West Pharmaceutical Services, Inc. 8.1×
RGEN Repligen Corporation compare 12.3×
Medical Instruments & Supplies industry median 2.9×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on WST